INMB
INmune Bio Inc
2.30$
-1.7%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -6.9% | -81,931.5% | -15,748.1% | -6,065.8% | -7,729.0% | -238,292.9% | -45,164.0% | |
| – | – | – | – | – | – | 69.6% | 63.9% | 144.5% | 0.0% | 168.0% | |
| – | – | – | – | 5.3% | 28,508.6% | 2,649.7% | 1,911.5% | 4,753.5% | 54,321.4% | 19,820.0% | |
| – | – | – | – | 5.3% | 28,508.6% | 2,649.7% | 1,911.5% | – | – | – | |
| – | – | – | – | -0.3% | 398.6% | -1,705.0% | -765.8% | 6,732.9% | 7,407.1% | -5,062.0% | |
| – | – | – | – | 0.0% | 0.0% | 8,287.3% | 0.0% | 0.0% | 0.0% | 2,084.0% | |
| – | – | – | – | -19.3% | -137,413.0% | -8,287.3% | – | – | – | -2,084.0% | |
| – | – | – | – | 15.7% | -9,270.8% | 44,975.7% | 8.0% | – | – | – | |
| – | – | – | – | 19.2% | 136,964.1% | 8,260.2% | 0.0% | -3,225.8% | -71,428.6% | 0.0% | |
| – | – | – | – | 15.7% | 218,906.0% | 53,235.9% | 194.9% | -2,725.8% | 130,078.6% | 55,224.0% | |
| – | – | – | – | 8.8% | 137,150.6% | 29,195.0% | -6,058.0% | -10,519.4% | -106,614.3% | 7,658.0% | |
| – | – | – | – | -6.9% | -81,931.6% | -24,035.4% | -6,065.8% | -7,729.0% | -238,292.9% | -47,248.0% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.